Pacific Biosciences of California, Inc. Stock

Market capitalization is the stock price multiplied by the number of shares issued.

Pacific Biosciences of California, Inc.

Enterprise value (EV) is a measure of the value of a company regardless of its financing. It is calculated as follows:
EV = market capitalization - cash + debt.

Enterprise Value metric explained

Pacific Biosciences of California, Inc.

The P/E ratio or price/earnings ratio TTM (Trailing Twelve Months) over the last 12 months describes the ratio of the stock price to earnings per share.

Pacific Biosciences of California, Inc.

If you divide the enterprise value by the Free Cash Flow of the last 12 months, you obtain an important metric for assessing the valuation of companies - even if they are not yet generating profits.

Pacific Biosciences of California, Inc.

If you divide the enterprise value by the revenue of the last 12 months, you obtain an important metric for assessing the valuation of companies - even if they are not yet making a profit.

Pacific Biosciences of California, Inc.

The KUV or price/sales ratio TTM (Trailing Twelve Months) over the last 12 months describes the ratio of the stock price to sales per share.

Pacific Biosciences of California, Inc.

The P/B ratio TTM (Trailing Twelve Months) over the last 12 months describes the ratio of the stock price to the book value per share.

Pacific Biosciences of California, Inc.

Sales growth TTM (Trailing Twelve Months) compares the sales of the last 12 months with the sales of the previous 12 months.

Pacific Biosciences of California, Inc.

Revenue TTM (Trailing Twelve Months) represents the sum of all revenues of a company for its products, services or other items within the last 12 months.

Pacific Biosciences of California, Inc.

EBIT or the operating result represents the profit or loss after deducting direct costs (cost of sales), sales, marketing, administrative, research and development costs and depreciation and amortization.

Pacific Biosciences of California, Inc.

Free Cash Flow TTM (Trailing Twelve Months) provides information on how much of the profit generated over the last 12 months remains in the company's coffers and is therefore available for profit distributions, share buybacks or debt repayment.

Pacific Biosciences of California, Inc.

Cash is defined as cash and cash equivalents (i.e. cash items of very high value).

Pacific Biosciences of California, Inc.

EPS TTM (Trailing Twelve Months) or earnings per share represents the profit per share over the last 12 months. The company's net profit is divided by the number of shares.

Pacific Biosciences of California, Inc.

Price/earnings ratio based on the expected net earnings per share for the financial year ending at Dec 31 2025.

Pacific Biosciences of California, Inc.

Ratio of market capitalization to sales on the basis of expected sales for the financial year ending at Dec 31 2025

Pacific Biosciences of California, Inc.

Ratio of enterprise value to sales based on estimated sales for the financial year ending at Dec 31 2025

Pacific Biosciences of California, Inc.